Amgen weight loss data ‘underwhelms,’ says Deutsche Bank
MariTide’s Phase 2 press release “underwhelms” with 20% weight loss from Cohort A and 17% weight loss from Cohort B at 52-weeks, with it being unclear if these are placebo adjusted. MariTide’s weight loss appears to miss the Street’s bogey of 25% weight loss and will weigh down Amgen shares,
New Drug Causes 20 Percent Weight Loss in Early Amgen Results
The drug, which is named MariTide and delivered in a monthly injection, is some time away from being sold. The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year.
Shares of General Motors and Ford fall after President-elect Donald Trump announces his tariff plans, while Amgen tumbles as ...
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), PepsiCo, Inc. (PEP) and Morgan Stanley (MS). On Monday, Eli Lilly And Co (NYSE ...
We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth. In this ...
Eli Lilly And Co (NYSE:LLY) shares are trading higher Tuesday after the Biden-Harris Administration proposed a new rule to ...
The Motley Fool on MSN3d
Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?Eli Lilly lost the momentum it had during the first half of the year. However, the company still has plenty of ...
The Converge platform validated as many as 83% of its treatment targets in disease models, a higher success rate than usual ...
Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...
The Motley Fool on MSN7d
Is It Time to Sell Eli Lilly and Pfizer Stocks?Eli Lilly now ranks as the largest drugmaker in the world based ... Much of Lilly's recent dismal stock performance ...
The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...
Madison Sustainable Equity Fund highlighted stocks like Eli Lilly and Company (NYSE:LLY) in the third quarter 2024 investor letter. Eli Lilly and Company (NYSE:LLY) is a pharmaceutical ...
Eli Lilly and Company (NYSE: LLY) announced today that it has elected Jon Moeller as a new member of its board of directors ...
We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback